Literature DB >> 30203744

Case Report: Atypical Cutaneous Leishmaniasis in a Patient with Mixed Leishmania guyanensis and Leishmania amazonensis Infection.

Carina Scolari Gosch1, Bruna Silva Resende2, Célia Bastos Amorim3, Cálita Pollyanna Marques4, Ledice Inacia de Araújo Pereira5, Sebastião Alves Pinto6, Silvia Reni Bortolin Uliana7, Adriano Cappellazzo Coelho8, Fátima Ribeiro-Dias4, Miriam Leandro Dorta4.   

Abstract

The disseminated form of leishmaniasis is a serious and rare disease, being diagnosed in 2% of the cutaneous cases registered per year in Brazil. The main characteristic is the appearance of multiple pleomorphic lesions on the cutaneous surface. A 68-year-old male from the rural area of Tocantins, Brazil, presented atypical disseminated cutaneous leishmaniasis (ACL). The clinical course and histopathological and immunological findings presented a mixed pattern that hindered diagnosis and therapeutic management. Molecular typing revealed a mixed infection with Leishmania (V.) guyanensis and Leishmania (L.) amazonensis. Molecular identification of the agents responsible for ACL is important for adequate therapeutic planning, minimizing the possibility of sequellae that impact the quality of life of the patient.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30203744      PMCID: PMC6221246          DOI: 10.4269/ajtmh.17-0760

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.

Authors:  Anette Chrusciak-Talhari; Reynaldo Dietze; Carolina Chrusciak Talhari; Roberto Moreira da Silva; Ellen Priscila Gadelha Yamashita; Gerson de Oliveira Penna; Paulo Roberto Lima Machado; Sinésio Talhari
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

2.  Leishmania (Viannia) guyanensis induces low immunologic responsiveness in leishmaniasis patients from an endemic area of the Brazilian Amazon Highland.

Authors:  Nubia Estela Matta; Ricardo S Nogueira; Antonia Maria Ramos Franco; Ilner de Souza E Souza; Marise S Mattos; Manoel P Oliveira-Neto; Sergio G Coutinho; Leonor L Leon; Alda Maria Da-Cruz
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

3.  Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis.

Authors:  E M Carvalho; A Barral; J M Costa; A Bittencourt; P Marsden
Journal:  Acta Trop       Date:  1994-04       Impact factor: 3.112

Review 4.  Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.

Authors:  Fernando T Silveira; Ralph Lainson; Claudia M C Gomes; Márcia D Laurenti; Carlos E P Corbett
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-07-03       Impact factor: 2.184

5.  Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.

Authors:  L H Guimarães; P R L Machado; E L Lago; D J Morgan; A Schriefer; O Bacellar; E M Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-05-28       Impact factor: 2.184

6.  Depletion of secondary lysosomes in mouse macrophages infected with Leishmania mexicana amazonensis: a cytochemical study.

Authors:  C L Barbieri; K Brown; M Rabinovitch
Journal:  Z Parasitenkd       Date:  1985

7.  Unusual clinical variants of cutaneous leishmaniasis in Pakistan.

Authors:  K M Raja; A A Khan; A Hameed; S B Rahman
Journal:  Br J Dermatol       Date:  1998-07       Impact factor: 9.302

8.  AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND RESPONSE TO TREATMENT.

Authors:  Andrea Claudia Bekner Silva Fernandes; Raíssa Bocchi Pedroso; Eneide Aparecida Sabaini Venazzi; Paulo Donizeti Zanzarini; Sandra Mara Alessi Aristides; Maria Valdrinez Campana Lonardoni; Thaís Gomes Verzignassi Silveira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-03-22       Impact factor: 1.846

9.  Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review.

Authors:  Yoshihisa Hashiguchi; Eduardo L Gomez; Hirotomo Kato; Luiggi R Martini; Lenin N Velez; Hiroshi Uezato
Journal:  Trop Med Health       Date:  2016-03-14

10.  Disseminated cutaneous leishmaniasis: ulcerovegetative and ulcero-crusted lesions.

Authors:  Isabela Martins Sgarbi; Flávia da Silva Domingos Santos; Veridiana Elisa Monteiro; Silvia Nunes Szente Fonseca; Fred Bernardes Filho
Journal:  Braz J Infect Dis       Date:  2016-12-21       Impact factor: 3.257

View more
  2 in total

1.  Development of an Amplicon-Based Next-Generation Sequencing Protocol to Identify Leishmania Species and Other Trypanosomatids in Leishmaniasis Endemic Areas.

Authors:  Luz H Patiño; Adriana C Castillo-Castañeda; Marina Muñoz; Jesus E Jaimes; Nicolas Luna-Niño; Carolina Hernández; Martha S Ayala; Patricia Fuya; Claudia Mendez; Carlos E Hernández-Pereira; Lourdes Delgado; Claudia M Sandoval-Ramírez; Plutarco Urbano; Alberto Paniz-Mondolfi; Juan David Ramírez
Journal:  Microbiol Spectr       Date:  2021-10-13

2.  Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo.

Authors:  Elizabeth M Coser; Bianca A Ferreira; Nilson Branco; Edite H Yamashiro-Kanashiro; José Angelo L Lindoso; Adriano C Coelho
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-08-15       Impact factor: 4.077

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.